Andrx to Meet With the FDA Around Thanksgiving

Drug Industry Daily
KEYWORDS ANDA / GMP / Patents / Regulations

Andrx plans to meet with the FDA around Thanksgiving to discuss manufacturing violations that have stalled approval of its drug applications. The company, which requested the meeting, said the FDA has not yet commented on any of its responses to the inspectional observations.

To View This Article:


Subscribe To Drug Industry Daily